All patientsn=182 Males n=159 (87.4%) Females n=23 (12.6%) p value
Age (yrs), median (IR) 47 (44-49) 47 (44-49) 46 (44-48) 0.434
BMI  (Kg/m2) , median (IR) 26.3 (24.7-28.6) 26.3 (24.9-28.7) 23.9 (22.7-26.7) 0.004
BMI (Kg/m2), frequency (%) 0.016
=25 56 (30.8) 43 (27.0) 13 (56.5)
>25 to  =30 95 (52.2) 87 (54.7) 8 (34.8)
>30 31 (17.0) 29 (18.2) 2 (8.7)
History of, frequency (%)  
Diabetes mellitus 27 (14.8) 20 (12.6) 7 (30.4) 0.024
Smoking 152 (83.5) 135 (84.9) 17 (73.9) 0.184
COPD 5 (2.7) 3 (1.9) 2 (8.7) 0.121*
Previous PCI 16 (8.8) 15 (9.4) 1 (4.3) 0.421
Previous MI 15 (8.2) 12 (7.5) 3 (13.0) 0.37
Hypertension 60 (33.0) 52 (32.7) 8 (34.8) 0.843
Symptom door-to-balloon time (minutes) , median (IR) 195 (120 to 300) 195 (120 to 290) 195 (140 to 375) 0.263
Admission Systolic arterial pressure (mmHg), median (IR) 125 (110-140) 125 (110-140) 120 (110-130) 0.174
Admission heart rate (bpm), median (IR) 76 (67-89) 75 (66-89) 78 (71-88) 0.232
AMI location, frequency (%) 0.011
Anterior 98 (53.8) 79 (49.7) 19 (82.6)
Inferior 72 (39.6) 68 (42.8) 4 (17.4)
Other 12 (6.6) 12 (7.5) 0 (0.0)
Coronary artery disease, frequency (%) 0.203
1-vessel 108 (59.3) 92 (57.9) 16 (69.6)
2-vessel 42 (23.1) 36 (22.6) 6 (26.1)
3 – vessel 32 (17.6) 31 (19.5) 1 (4.3)
PCI failure, frequency (%) 3 (1.7) 2 (1.3) 1 (4.5) 0.325*
Killip, frequency (%) 0.186
1-II 170 (93.4) 150 (94.3) 20 (87.8)
III-IV 12 (6.6) 9 (5.7) 3 (13.0)
Admission LVEF (%), median (IR) 45 (40-52) 45 (40-52) 45 (40-51) 0.695
Discharge LVEF (%), median (IR) 48 (43-54) 50 (44-55) 46 (42.5-50) 0.164
In-ICCU mortality, frequency (%) 4 (2.2) 3 (1.9) 1 (4.3) 0.420*
Total mortality, frequency (%) 7/125 (5.6) 5/111 (4.5) 2/14 (14.3) 0.134
total follow-up (months), median (IR) 37 (15-63) 34 (14-62) 52 (32-65) 0.315

*Fisher’s exact test

BMI: body mass index; COPD: chronic obstructive pulmonary disease; PCI: percutaneous coronary intervention; MI: myocardial infarction; AMI: acute myocardial infarction; LVEF: left ventricular ejection fraction, ICCU: intensive cardiac care unit;

Table 2 Clinical and angiographic data of the study population